Impax Asset Management Group PLC Catalent, Inc. Transaction History

Impax Asset Management Group PLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$94.19 - $124.49 $229,258 - $303,008	-2,434 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$119.57 - $139.07 $7,891 - $9,178	-66 Reduced 2.64%	2,434 $312,000
Q3 2021 Nov 12, 2021	BUY	$109.17 - $142.35 $272,925 - $355,875	2,500 New	2,500 $333,000
Q1 2019 May 13, 2019	SELL	$29.84 - $43.92 $1.07 Million - $1.57 Million	-35,791 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$29.95 - $46.34 $10.4 Million - $16.2 Million	-348,512 Reduced 90.69%	35,791 $1.12 Million
Q3 2018 Nov 14, 2018	BUY	$40.12 - $45.55 $15.4 Million - $17.5 Million	384,303 New	384,303 $17.5 Million

484

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Impax Asset Management Group PLC, based on Form 13F filings with the SEC.

Stay updated on Impax Asset Management Group PLC with notifications on news.